Sublingual immunotherapy for allergic rhinitis
Radulovic S, Calderon MA, Wilson D, Durham S
Published in Cochrane Database of Systematic Reviews
Abstract
Cochrane review of RCTs evaluating the efficacy and safety of sublingual immunotherapy compared with placebo for allergic rhinoconjunctivitis.
Methodology
Meta-analysis of double-blind, placebo-controlled RCTs of sublingual immunotherapy in adults and children with allergic rhinitis.
Key Findings
Sublingual immunotherapy significantly reduced both symptom scores and medication use compared with placebo, with a favorable safety profile.
Conclusions
Sublingual immunotherapy is an effective and generally well-tolerated alternative to subcutaneous immunotherapy for allergic rhinitis.
Limitations
Significant heterogeneity among trials in allergen extracts, dosing regimens, and outcome measures; long-term effects less well established.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.